Drug Profile
Research programme: serotonin/histamine antagonists - Evolutec
Alternative Names: EV 598; rEV 598Latest Information Update: 19 Mar 2008
Price :
$50
*
At a glance
- Originator Evolutec
- Class Antiemetics; Antineoplastics; Glycoproteins
- Mechanism of Action Histamine release inhibitors; Serotonin receptor antagonists; Serotonin release inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Malignant carcinoid syndrome; Nausea and vomiting
Most Recent Events
- 25 Oct 2006 Suspended - Preclinical for Emesis in United Kingdom (Parenteral)
- 14 Mar 2006 EV 598 is available for licensing (http://www.evolutec.co.uk)
- 05 Sep 2005 This compound is still in active development - (BIO-2005)